Literature DB >> 19783992

Unmasking the tonic-aversive state in neuropathic pain.

Tamara King1, Louis Vera-Portocarrero, Tannia Gutierrez, Todd W Vanderah, Gregory Dussor, Josephine Lai, Howard L Fields, Frank Porreca.   

Abstract

Tonic pain has been difficult to demonstrate in animals. Because relief of pain is rewarding, analgesic agents that are not rewarding in the absence of pain should become rewarding only when there is ongoing pain. We used conditioned place preference to concomitantly determine the presence of tonic pain in rats and the efficacy of agents that relieve it. This provides a new approach for investigating tonic pain in animals and for evaluating the analgesic effects of drugs.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19783992      PMCID： PMC3427725          DOI： 10.1038/nn.2407

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


  13 in total

1.  The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex.

Authors:  J P Johansen; H L Fields; B H Manning
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 2.  State-dependent opioid control of pain.

Authors:  Howard Fields
Journal:  Nat Rev Neurosci       Date:  2004-07       Impact factor: 34.870

Review 3.  Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards.

Authors:  Andrew S C Rice; Dorothy Cimino-Brown; James C Eisenach; Vesa K Kontinen; Michael L Lacroix-Fralish; Ian Machin; Jeffrey S Mogil; Thomas Stöhr
Journal:  Pain       Date:  2008-09-23       Impact factor: 6.961

Review 4.  Mechanisms of neuropathic pain.

Authors:  James N Campbell; Richard A Meyer
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

5.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain.

Authors:  Isabelle Decosterd; Clifford J Woolf
Journal:  Pain       Date:  2000-08       Impact factor: 6.961

6.  Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.

Authors:  Thomas J Martin; Susy A Kim; Nancy L Buechler; Frank Porreca; James C Eisenach
Journal:  Anesthesiology       Date:  2007-02       Impact factor: 7.892

7.  Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain.

Authors:  James C Eisenach; Richard L Rauck; Regina Curry
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

Review 8.  Mechanisms of neuropathic pain and their implications for the design of clinical trials.

Authors:  Michael C Rowbotham
Journal:  Neurology       Date:  2005-12-29       Impact factor: 9.910

9.  Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.

Authors:  Shannon E Burgess; Luis R Gardell; Michael H Ossipov; T Philip Malan; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

10.  Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli.

Authors:  Mark A Ungless; Peter J Magill; J Paul Bolam
Journal:  Science       Date:  2004-03-26       Impact factor: 47.728
View more
  251 in total

1.  Conditioned place preference reveals tonic pain in an animal model of central pain.

Authors:  Leyla Davoody; Raimi L Quiton; Jessica M Lucas; Yadong Ji; Asaf Keller; Radi Masri
Journal:  J Pain       Date:  2011-04-23       Impact factor: 5.820

Review 2.  Spinal cord stimulation: neurophysiological and neurochemical mechanisms of action.

Authors:  Yun Guan
Journal:  Curr Pain Headache Rep       Date:  2012-06

3.  Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids.

Authors:  Eric E Ewan; Thomas J Martin
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

4.  Tuning out the noise: limbic-auditory interactions in tinnitus.

Authors:  Josef P Rauschecker; Amber M Leaver; Mark Mühlau
Journal:  Neuron       Date:  2010-06-24       Impact factor: 17.173

Review 5.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

6.  Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.

Authors:  Stephanie Shiers; Grishma Pradhan; Juliet Mwirigi; Galo Mejia; Ayesha Ahmad; Sven Kroener; Theodore Price
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

7.  Suppression of voluntary wheel running in rats is dependent on the site of inflammation: evidence for voluntary running as a measure of hind paw-evoked pain.

Authors:  Peter M Grace; Keith A Strand; Steven F Maier; Linda R Watkins
Journal:  J Pain       Date:  2013-10-12       Impact factor: 5.820

8.  Ionic plasticity and pain: The loss of descending serotonergic fibers after spinal cord injury transforms how GABA affects pain.

Authors:  Yung-Jen Huang; James W Grau
Journal:  Exp Neurol       Date:  2018-05-02       Impact factor: 5.330

Review 9.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.

Authors:  Zachary A Curry; Jenny L Wilkerson; Deniz Bagdas; S Lauren Kyte; Nipa Patel; Giulia Donvito; Mohammed A Mustafa; Justin L Poklis; Micah J Niphakis; Ku-Lung Hsu; Benjamin F Cravatt; David A Gewirtz; M Imad Damaj; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2018-03-14       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.